Breast Cancer Res Treat (2017) 166: 593.

Laura J. van ‘t Veer, Christina Yau, Nancy Y. Yu, Christopher C. Benz, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Laura J. Esserman, Linda Sofie Lindström

20yr BCSS and 10yr DMFS analysis of MammaPrint High Risk vs Low Risk patients in the STO trial.

Read more: van’t Veer et al_2017_Breast Cancer Research and Treatment_Tamoxifen Therapy Benefit…